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Deep learning, a state-of-the-art machine learning approach, has shown outstanding
performance over traditional machine learning in identifying intricate structures in
complex high-dimensional data, especially in the domain of computer vision. The
application of deep learning to early detection and automated classification of
Alzheimer’s disease (AD) has recently gained considerable attention, as rapid progress
in neuroimaging techniques has generated large-scale multimodal neuroimaging data.
A systematic review of publications using deep learning approaches and neuroimaging
data for diagnostic classification of AD was performed. A PubMed and Google Scholar
search was used to identify deep learning papers on AD published between January
2013 and July 2018. These papers were reviewed, evaluated, and classified by algorithm
and neuroimaging type, and the findings were summarized. Of 16 studies meeting
full inclusion criteria, 4 used a combination of deep learning and traditional machine
learning approaches, and 12 used only deep learning approaches. The combination
of traditional machine learning for classification and stacked auto-encoder (SAE) for
feature selection produced accuracies of up to 98.8% for AD classification and 83.7%
for prediction of conversion from mild cognitive impairment (MCI), a prodromal stage
of AD, to AD. Deep learning approaches, such as convolutional neural network (CNN)
or recurrent neural network (RNN), that use neuroimaging data without pre-processing
for feature selection have yielded accuracies of up to 96.0% for AD classification
and 84.2% for MCI conversion prediction. The best classification performance was
obtained when multimodal neuroimaging and fluid biomarkers were combined. Deep
learning approaches continue to improve in performance and appear to hold promise
for diagnostic classification of AD using multimodal neuroimaging data. AD research that
uses deep learning is still evolving, improving performance by incorporating additional
hybrid data types, such as—omics data, increasing transparency with explainable
approaches that add knowledge of specific disease-related features and mechanisms.
Keywords: artificial intelligence, machine learning, deep learning, classification, Alzheimer’s disease,
neuroimaging, magnetic resonance imaging, positron emission tomography
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INTRODUCTION
Alzheimer’s disease (AD), the most common form of dementia,
is a major challenge for healthcare in the twenty-first century. An
estimated 5.5million people aged 65 and older are living with AD,
and AD is the sixth-leading cause of death in the United States.
The global cost of managing AD, including medical, social
welfare, and salary loss to the patients’ families, was $277 billion
in 2018 in the United States, heavily impacting the overall
economy and stressing the U.S. health care system (Alzheimer’s
Association, 2018). AD is an irreversible, progressive brain
disorder marked by a decline in cognitive functioning with no
validated disease modifying treatment (De strooper and Karran,
2016). Thus, a great deal of effort has been made to develop
strategies for early detection, especially at pre-symptomatic stages
in order to slow or prevent disease progression (Galvin, 2017;
Schelke et al., 2018). In particular, advanced neuroimaging
techniques, such as magnetic resonance imaging (MRI) and
positron emission tomography (PET), have been developed
and used to identify AD-related structural and molecular
biomarkers (Veitch et al., 2019). Rapid progress in neuroimaging
techniques has made it challenging to integrate large-scale,
high dimensional multimodal neuroimaging data. Therefore,
interest has grown rapidly in computer-aided machine learning
approaches for integrative analysis. Well-known pattern analysis
methods, such as linear discriminant analysis (LDA), linear
program boosting method (LPBM), logistic regression (LR),
support vector machine (SVM), and support vector machine-
recursive feature elimination (SVM-RFE), have been used and
hold promise for early detection of AD and the prediction of AD
progression (Rathore et al., 2017).
In order to apply such machine learning algorithms,
appropriate architectural design or pre-processing steps must
be predefined (Lu and Weng, 2007). Classification studies using
machine learning generally require four steps: feature extraction,
feature selection, dimensionality reduction, and feature-based
classification algorithm selection. These procedures require
specialized knowledge andmultiple stages of optimization, which
may be time-consuming. Reproducibility of these approaches has
been an issue (Samper-Gonzalez et al., 2018). For example, in the
feature selection process, AD-related features are chosen from
various neuroimaging modalities to derive more informative
combinatorial measures, which may include mean subcortical
volumes, gray matter densities, cortical thickness, brain glucose
metabolism, and cerebral amyloid-β accumulation in regions of
interest (ROIs), such as the hippocampus (Riedel et al., 2018).
In order to overcome these difficulties, deep learning, an
emerging area of machine learning research that uses raw
neuroimaging data to generate features through “on-the-fly”
learning, is attracting considerable attention in the field of large-
scale, high-dimensional medical imaging analysis (Plis et al.,
2014). Deep learning methods, such as convolutional neural
networks (CNN), have been shown to outperform existing
machine learning methods (Lecun et al., 2015).
We systematically reviewed publications where deep learning
approaches and neuroimaging data were used for the early
detection of AD and the prediction of AD progression. A
PubMed and Google Scholar search was used to identify deep
learning papers on AD published between January 2013 and
July 2018. The papers were reviewed and evaluated, classified
by algorithms and neuroimaging types, and the findings were
summarized. In addition, we discuss challenges and implications
for the application of deep learning to AD research.
DEEP LEARNING METHODS
Deep learning is a subset of machine learning (Lecun et al.,
2015), meaning that it learns features through a hierarchical
learning process (Bengio, 2009). Deep learning methods for
classification or prediction have been applied in various fields,
including computer vision (Ciregan et al., 2012; Krizhevsky
et al., 2012; Farabet et al., 2013) and natural language processing
(Hinton et al., 2012; Mikolov et al., 2013), both of which
demonstrate breakthroughs in performance (Boureau et al., 2010;
Russakovsky et al., 2015). Because deep learning methods have
been reviewed extensively in recent years (Bengio, 2013; Bengio
et al., 2013; Schmidhuber, 2015), we focus here on basic concepts
of Artificial Neural Networks (ANN) that underlie deep learning
(Hinton and Salakhutdinov, 2006). We also discuss architectural
layouts of deep learning that have been applied to the task of
AD classification and prognostic prediction. ANN is a network
of interconnected processing units called artificial neurons that
were modeled (Mcculloch and Pitts, 1943) and developed with
the concept of Perceptron (Rosenblatt, 1957, 1958), Group
Method of DataHandling (GMDH) (Ivakhnenko and Lapa, 1965;
Ivakhnenko, 1968, 1971), and the Neocognitron (Fukushima,
1979, 1980). Efficient error functions and gradient computing
methods were discussed in these seminal publications, spurred
by the demonstrated limitation of the single layer perceptron,
which can learn only linearly separable patterns (Minsky and
Papert, 1969). Further, the back-propagation procedure, which
uses gradient descent, was developed and applied to minimize
the error function (Werbos, 1982, 2006; Rumelhart et al., 1986;
Lecun et al., 1988).
Gradient Computation
The back-propagation procedure is used to calculate the error
between the network output and the expected output. The back
propagation calculates the gap repeatedly, changing weights and
stopping the calculation when the gap is no longer updated
(Rumelhart et al., 1986; Bishop, 1995; Ripley and Hjort, 1996;
Schalkoff, 1997). Figure 1 illustrates the process of the neural
network made by multilayer perceptron. After the initial error
value is calculated from the given random weight by the least
squares method, the weights are updated until the differential
value becomes 0. For example, the w31 in Figure 1 is updated by
the following formula:
w31 (t+1)=w31t−
∂ErrorYout
∂w31
ErrorYout=
1
2
(
yt1−yo1
)2
+
1
2
(
yt2−yo2
)2
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FIGURE 1 | The multilayer perceptron procedure. After the initial error value is calculated from the given random weight by the least squares method, the weights are
updated by a back-propagation algorithm until the differential value becomes 0.
The ErrorYout is the sum of error yo1 and error yo2. yt1, yt2 are
constants that are known through the given data. The partial
derivative of ErrorYout with respect to w31 can be calculated by
the chain rule as follows.
∂ErrorYout
∂w31
=
∂ErrorYout
∂yo1
·
∂yo1
∂net3
·
∂net3
∂w31
Likewise, w11 in the hidden layer is updated by the chain rule
as follows.
∂ErrorYout
∂w11
=
∂ErrorYout
∂yh1
·
∂yh1
∂net1y
·
∂net1
∂w11
Detailed calculation of the weights in the backpropagation is
described in Supplement 1.
Modern Practical Deep Neural Networks
As the back-propagation uses a gradient descent method to
calculate the weights of each layer going backwards from the
output layer, a vanishing gradient problem occurs as the layer
is stacked, where the differential value becomes 0 before finding
the optimum value. As shown in Figure 2A, when the sigmoid
is differentiated, the maximum value is 0.25, which becomes
closer to 0 when it continues to multiply. This is called a
vanishing gradient issue, a major obstacle of the deep neural
network. Considerable research has addressed the challenge of
the vanishing gradient (Goodfellow et al., 2016). One of the
accomplishments of such an effort is to replace the sigmoid
function, an activation function, with several other functions,
such as the hyperbolic tangent function, ReLu, and Softplus (Nair
and Hinton, 2010; Glorot et al., 2011). The hyperbolic tangent
(tanh, Figure 2B) function expands the range of derivative values
of the sigmoid. The ReLu function (Figure 2C), the most used
activation function, replaces a value with 0 when the value is <0
and uses the value if the value is >0. As the derivative becomes
1, when the value is larger than 0, it becomes possible to adjust
the weights without disappearing up to the first layer through
the stacked hidden layers. This simple method allows building
multiple layers and accelerates the development of deep learning.
The Softplus function (Figure 2D) replaces the ReLu function
with a gradual descent method when ReLu becomes zero.
While a gradient descent method is used to calculate
the weights accurately, it usually requires a large amount
of computation time because all of the data needs to
be differentiated at each update. Thus, in addition to the
activation function, advanced gradient descent methods have
been developed to solve speed and accuracy issues. For example,
Stochastic Gradient Descent (SGD) uses a subset that is
randomly extracted from the entire data for faster and more
frequent updates (Bottou, 2010), and it has been extended to
Momentum SGD (Sutskever et al., 2013). Currently, one of the
most popular gradient descent method is Adaptive Moment
Estimation (Adam). Detailed calculation of the optimization
methods is described in Supplement 2.
Architectures of Deep Learning
Overfitting has also played a major role in the history of
deep learning (Schmidhuber, 2015), with efforts being made
to solve it at the architectural level. The Restricted Boltzmann
Machine (RBM) was one of the first models developed to
overcome the overfitting problem (Hinton and Salakhutdinov,
2006). Stacking the RBMs resulted in building deeper structures
known as the Deep Boltzmann Machine (DBM) (Salakhutdinov
and Larochelle, 2010). The Deep Belief Network (DBN) is
a supervised learning method used to connect unsupervised
features by extracting data from each stacked layer (Hinton et al.,
2006). DBN was found to have a superior performance to other
models and is one of the reasons that deep learning has gained
popularity (Bengio, 2009). While DBN solves the overfitting
problem by reducing the weight initialization using RBM, CNN
efficiently reduces the number of model parameters by inserting
convolution and pooling layers that lead to a reduction in
complexity. Because of its effectiveness, when given enough
data, CNN is widely used in the field of visual recognition.
Figure 3 shows the structures of RBM, DBM, DBN, CNN,
Auto-Encoders (AE), sparse AE, and stacked AE, respectively.
Auto-Encoders (AE) are an unsupervised learning method that
make the output value approximate to the input value by using
the back-propagation and SGD (Hinton and Zemel, 1994). AE
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FIGURE 2 | Common activation functions used in deep learning (red) and their derivatives (blue). When the sigmoid is differentiated, the maximum value is 0.25, which
becomes closer to 0 when it continues to multiply.
engages the dimensional reduction, but it is difficult to train
due to the vanishing gradient issue. Sparse AE has solved
this issue by allowing for only a small number of the hidden
units (Makhzani and Frey, 2015). Stacked AE stacks sparse AE
like DBN.
DNN, RBM, DBM, DBN, AE, Sparse AE, and Stacked AE
are deep learning methods that have been used for Alzheimer’s
disease diagnostic classification to date (see Table 1 for the
definition of acronyms). Each approach has been developed to
classify AD patients from cognitively normal controls (CN) or
mild cognitive impairment (MCI), which is the prodromal stage
of AD. Each approach is used to predict the conversion of MCI
to AD using multi-modal neuroimaging data. In this paper,
when deep learning is used together with traditional machine
learning methods, i.e., SVM as a classifier, it is referred to as a
“hybrid method.”
MATERIALS AND METHODS
We conducted a systematic review on previous studies that used
deep learning approaches for diagnostic classification of AD with
multimodal neuroimaging data. The search strategy is outlined
in detail using the PRISMA flow diagram (Moher et al., 2009)
in Figure 4.
Identification
From a total of 389 hits on Google scholar and PubMed search,
16 articles were included in the systematic review.
Google Scholar: We searched using the following key words
and yielded 358 results (“Alzheimer disease” OR “Alzheimer’s
disease”), (“deep learning” OR “deep neural network” OR
“CNN” OR “CNN” OR “Autoencoder” OR “DBN” OR “RBM”),
(“Neuroimaging” OR “MRI” OR “multimodal”).
PubMed: The keywords used in the Google Scholar search
were reused for the search in PubMed, and yielded 31 search
results (“Alzheimer disease” OR “Alzheimer’s disease”) AND
(“deep learning” OR “deep neural network” OR “CNN” OR
“recurrent neural network” OR “Auto-Encoder” OR “Auto
Encoder” OR “RBM” OR “DBN” OR “Generative Adversarial
Network” OR “Reinforcement Learning” OR “Long Short Term
Memory” OR “Gated Recurrent Units”) AND (“Neuroimaging”
OR “MRI” OR “multimodal”).
Among the 389 relevant records, 25 overlapping records
were removed.
Screening Based on Article Type
We first excluded 38 survey papers, 22 theses, 19 Preprint, 34
book chapters, 20 conference abstract, 13 none English papers,
5 citations, and 10 patents. We also excluded 11 papers of which
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FIGURE 3 | Architectural structures in deep learning: (A) RBM (Hinton and Salakhutdinov, 2006) (B) DBM (Salakhutdinov and Larochelle, 2010) (C) DBN (Bengio,
2009) (D) CNN (Krizhevsky et al., 2012) (E) AE (Fukushima, 1975; Krizhevsky and Hinton, 2011) (F) Sparse AE (Vincent et al., 2008, 2010) (G) Stacked AE (Larochelle
et al., 2007; Makhzani and Frey, 2015). RBM, Restricted Boltzmann Machine; DBM, Deep Boltzmann Machine; DBN, Deep Belief Network; CNN, Convolutional
Neural Network; AE, Auto-Encoders.
TABLE 1 | Definition of acronyms.
Acronym Description Acronym Description
ANN Artificial neural network CNN Convolutional neural
network
DNN Deep neural network RNN Recurrent neural network
RBM Restricted Boltzmann
machine
GAN Generative adversarial
networks
DBM Deep Boltzmann
machine
SGD Stochastic gradient descent
DBN Deep belief network SVM Support vector machine
AE Auto-encoders ROI Regions of interest
SAE Stacked auto-encoder HMM Hidden markov model
the full text was not accessible. The remaining 192 articles were
downloaded for review.
Eligibility Screening
Out of the 192 publications retrieved, 150 articles were
excluded because the authors only introduced or mentioned
deep learning but did not use it. Out of the 42 remaining
publications, (1) 18 articles were excluded because they did
not perform deep learning approaches for AD classification
and/or prediction of MCI to AD conversion; (2) 5 articles
were excluded because their neuroimaging data were not
explicitly described; and (3) 3 articles were excluded because
performance results were not provided. The remaining 16
papers were included in this review for AD classification
and/or prediction of MCI to AD conversion. All of the
final selected and compared papers used ADNI data
in common.
RESULTS
From the 16 papers included in this review, Table 2 provides
the top results of diagnostic classification and/or prediction of
MCI to AD conversion. We compared only binary classification
results. Accuracy is a measure used consistently in the 16
publications. However, it is only one metric of the performance
characteristics of an algorithm. The group composition, sample
sizes, and number of scans analyzed are also noted together
because accuracy is sensitive to unbalanced distributions.
Table S1 shows the full results sorted according to the
performance accuracy as well as the number of subjects, the
deep learning approach, and the neuroimaging type used in
each paper.
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FIGURE 4 | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Flow Chart. From a total of 389 hits on Google scholar and PubMed
search, 16 articles were included in the systematic review.
Deep Learning for Feature Selection From
Neuroimaging Data
Multimodal neuroimaging data have been used to identify
structural and molecular/functional biomarkers for AD. It has
been shown that volumes or cortical thicknesses in pre-selected
AD-specific regions, such as the hippocampus and entorhinal
cortex, could be used as features to enhance the classification
accuracy in machine learning. Deep learning approaches have
been used to select features from neuroimaging data.
As shown in Figure 5, 4 studies have used hybridmethods that
combine deep learning for feature selection from neuroimaging
data and traditional machine learning, such as the SVM as a
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TABLE 2 | Summary of 16 previous studies to systematically be reviewed.
References Modality Data
processing/training
Classifier AD:NC
acc.
SEN SPE cMCI:ncMCI
acc.
SEN SPE AD cMCI ncMCI NC Total
Suk and Shen (2013) MRI, PET,
CSF
SAE SVM 95.9 75.8 51 43 56 52 202
Liu et al. (2014) MRI, PET SAE + NN Softmax 87.76 88.57 87.22 76.92
(MCI:NC)
74.29 78.13 65 67 102 77 311
Suk et al. (2014) MRI, PET DBM SVM 95.35 94.65 95.22 75.92
86.75
(MCI:NC)
48.04
95.37
95.23
65.87
93 76 128 101 398
Li et al. (2014) MRI, PET 3D CNN Logistic
regression
92.87
76.21
(MCI:NC)
198 167 236 229 830
Li et al. (2015) MRI, PET,
CSF
RBM + drop out SVM 91.4 57.4
76.21
(MCI:NC)
51 43 56 52 202
Suk et al. (2015) MRI, PET,
CSF
SAE + sparse learning SVM 98.8 83.3
90.7
(MCI:NC)
51 43 56 52 202
Liu et al. (2015) MRI, PET SAE with zero-masking Softmax 91.4 92.32 90.42 82.1
(MCI:NC)
60.0 92.32 77 67 102 85 331
Cheng et al. (2017) MRI 3D CNN Softmax 87.15 86.36 85.93 199 229 428
Cheng and Liu (2017) MRI, PET 3D CNN + 2D CNN Softmax 89.64 87.10 92.00 93 100 193
Aderghal et al. (2017) MRI 2D CNN Softmax 91.41 93.75 89.06 65.62
(MCI:NC)
66.25 65.0 188 399 (MCI) 228 815
Korolev et al. (2017) MRI 3D CNN Softmax 80 87 (AUC) 61 (lMCI:NC) 65 (AUC) 50 43 (lMCI) 77 (eMCI) 61 111
56 (lMCI:NC) 58 (AUC)
Vu et al. (2017) MRI, PET SAE + 3D CNN Softmax 91.14 145 172 317
Liu et al. (2018a) PET RNN Softmax 91.2 91.4 91.0 78.9
(MCI:NC)
78.01 80.0 93 146 (MCI) 100 339
Liu et al. (2018b) MRI Landmark detection +
3D CNN
Softmax 91.09 88.05 93.50 76.9 42.11 82.43 159 38 239 200 636
Lu et al. (2018) MRI, PET DNN + NN Softmax 84.6 80.2 91.8 82.93 79.69 83.84 238 217 409 360 1224
Choi and Jin (2018) PET 3D CNN Softmax 96 93.5 97.8 84.2 81.0 87.0 139 79 92 182 492
SEN = TP/(TP + FN), SPE = TN/(TN + FP). TP, true positive; TN, true negative; FP, false positive; FN, false negative. All data on this table were from ADNI.
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FIGURE 5 | Comparison of diagnostic classification accuracy of pure deep learning and hybrid approach. Four studies (gray) have used hybrid methods that combine
deep learning for feature selection from neuroimaging data and traditional machine learning, such as the SVM as a classifier. Twelve studies (blue) have used deep
learning method with softmax classifier for diagnostic classification and/or prediction of MCI to AD conversion. (A) Accuracy comparison between articles. (B) Number
of studies published per year. (C) Average classification accuracy of each methods.
classifier. Suk and Shen (2013) used a stacked auto-encoder (SAE)
to construct an augmented feature vector by concatenating the
original features with outputs of the top hidden layer of the
representative SAEs. Then, they used a multi-kernel SVM for
classification to show 95.9% accuracy for AD/CN classification
and 75.8% prediction accuracy of MCI to AD conversion.
These methods successfully tuned the input data for the SVM
classifier. However, SAE as a classifier (Suk et al., 2015) yielded
89.9% accuracy for AD/CN classification and 60.2% accuracy for
prediction of MCI to AD conversion. Later Suk et al. (2015)
extended the work to develop a two-step learning scheme: greedy
layer-wise pre-training and fine-tuning in deep learning. The
same authors further extended their work to use the DBM to
find latent hierarchical feature representations by combining
heterogeneous modalities during the feature representation
learning (Suk et al., 2014). They obtained 95.35% accuracy for
AD/CN classification and 74.58% prediction accuracy of MCI
to AD conversion. In addition, the authors initialized SAE
parameters with target-unrelated samples and tuned the optimal
parameters with target-related samples to have 98.8% accuracy
for AD/CN classification and 83.7% accuracy for prediction of
MCI to AD conversion (Suk et al., 2015). Li et al. (2015) used
the RBM with a dropout technique to reduce overfitting in deep
learning and SVM as a classifier, which produced 91.4% accuracy
for AD/CN classification and 57.4% prediction accuracy of MCI
to AD conversion.
Deep Learning for Diagnostic
Classification and Prognostic Prediction
To select optimal features from multimodal neuroimaging
data for diagnostic classification, we usually need several pre-
processing steps, such as neuroimaging registration and feature
extraction, which greatly affect the classification performance.
However, deep learning approaches have been applied to
AD diagnostic classification using original neuroimaging data
without any feature selection procedures.
As shown in Figure 5, 12 studies have used only deep
learning for diagnostic classification and/or prediction of MCI
to AD conversion. Liu et al. (2014) used stacked sparse auto-
encoders (SAEs) and a softmax regression layer and showed
87.8% accuracy for AD/CN classification. Liu et al. (2015) used
SAE and a softmax logistic regressor as well as a zero-mask
strategy for data fusion to extract complementary information
from multimodal neuroimaging data (Ngiam et al., 2011), where
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one of the modalities is randomly hidden by replacing the
input values with zero to converge different types of image data
for SAE. Here, the deep learning algorithm improved accuracy
for AD/CN classification by 91.4%. Recently, Lu et al. (2018)
used SAE for pre-training and DNN in the last step, which
achieved an AD/CN classification accuracy of 84.6% and an
MCI conversion prediction accuracy of 82.93%. CNN, which has
shown remarkable performance in the field of image recognition,
has also been used for the diagnostic classification of AD with
multimodal neuroimaging data. Cheng et al. (2017) used image
patches to transform the local images into high-level features
from the original MRI images for the 3D-CNN and yielded 87.2%
accuracy for AD/CN classification. They improved the accuracy
to 89.6% by running two 3D-CNNs on neuroimage patches
extracted from MRI and PET separately and by combining
their results to run 2D CNN (Cheng and Liu, 2017). Korolev
et al. (2017) applied two different 3D CNN approaches [plain
(VoxCNN) and residual neural networks (ResNet)] and reported
80% accuracy for AD/CN classification, which was the first
study that the manual feature extraction step was unnecessary.
Aderghal et al. (2017) captured 2D slices from the hippocampal
region in the axial, sagittal, and coronal directions and applied 2D
CNN to show 85.9% accuracy for AD/CN classification. Liu et al.
(2018b) selected discriminative patches from MR images based
on AD-related anatomical landmarks identified by a data-driven
learning approach and ran 3D CNN on them. This approach
used three independent data sets (ADNI-1 as training, ADNI-
2 and MIRIAD as testing) to yield relatively high accuracies
of 91.09 and 92.75% for AD/CN classification from ADNI-2
and MIRIAD, respectively, and an MCI conversion prediction
accuracy of 76.9% from ADNI-2. Li et al. (2014) trained 3D CNN
models on subjects with both MRI and PET scans to encode the
non-linear relationship between MRI and PET images and then
used the trained network to estimate the PET patterns for subjects
with onlyMRI data. This study obtained an AD/CN classification
accuracy of 92.87% and an MCI conversion prediction accuracy
of 72.44%. Vu et al. (2017) applied SAE and 3D CNN to subjects
with MRI and FDG PET scans to yield an AD/CN classification
accuracy of 91.1%. Liu et al. (2018a) decomposed 3D PET images
into a sequence of 2D slices and used a combination of 2D
CNN and RNNs to learn the intra-slice and inter-slice features
for classification, respectively. The approach yielded AD/CN
classification accuracy of 91.2%. If the data is imbalanced, the
chance of misdiagnosis increases and sensitivity decreases. For
example, in Suk et al. (2014) there were 76 cMCI and 128 ncMCI
subjects and the obtained sensitivity of 48.04%was low. Similarly,
Liu et al. (2018b) included 38 cMCI and 239 ncMCI subjects and
had a low sensitivity of 42.11%. Recently Choi and Jin (2018)
reported the first use of 3D CNN models to multimodal PET
images [FDG PET and [18F]florbetapir PET] and obtained 96.0%
accuracy for AD/CN classification and 84.2% accuracy for the
prediction of MCI to AD conversion.
Performance Comparison by Types of
Neuroimaging Techniques
In order to improve the performance for AD/CN classification
and for the prediction of MCI to AD conversion, multimodal
neuroimaging data such as MRI and PET have commonly been
used in deep learning: MRI for brain structural atrophy, amyloid
PET for brain amyloid-β accumulation, and FDG-PET for brain
glucose metabolism. MRI scans were used in 13 studies, FDG-
PET scans in 10, both MRI and FDG-PET scans in 12, and
both amyloid PET and FDG-PET scans in 1. The performance
in AD/CN classification and/or prediction of MCI to AD
conversion yielded better results in PET data compared to MRI.
Two or more multimodal neuroimaging data types produced
FIGURE 6 | Changes in accuracy by types of image resource. MRI scans were used in 13 studies, FDG-PET scans in 10, both MRI and FDG-PET scans in 12, and
both amyloid PET and FDG-PET scans in 1. The performance in AD/CN classification yielded better results in PET data compared to MRI. Two or more multimodal
neuroimaging data types produced higher accuracies than a single neuroimaging technique.
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higher accuracies than a single neuroimaging technique. Figure 6
shows the results of the performance comparison by types of
neuroimaging techniques.
Performance Comparison by Deep
Learning Algorithms
Deep learning approaches require massive amounts of data
to achieve the desired levels of performance accuracy. In
currently limited neuroimaging data, the hybrid methods
that combine traditional machine learning methods for
diagnostic classification with deep learning approaches for
feature extraction yielded better performance and can be a
good alternative to handle the limited data. Here, an auto-
encoder (AE) was used to decode the original image values,
making them similar to the original image, which it then
included as input, thereby effectively utilizing the limited
neuroimaging data. Although hybrid approaches have yielded
relatively good results, they do not take full advantage of deep
learning, which automatically extracts features from large
amounts of neuroimaging data. The most commonly used deep
learning method in computer vision studies is the CNN, which
specializes in extracting characteristics from images. Recently,
3D CNN models using multimodal PET images [FDG-PET and
[18F]florbetapir PET] showed better performance for AD/CN
classification and for the prediction of MCI to AD conversion.
DISCUSSION
Effective and accurate diagnosis of Alzheimer’s disease (AD)
is important for initiation of effective treatment. Particularly,
early diagnosis of AD plays a significant role in therapeutic
development and ultimately for effective patient care. In this
study, we performed a systematic review of deep learning
approaches based on neuroimaging data for diagnostic
classification of AD. We analyzed 16 articles published
between 2013 and 2018 and classified them according to deep
learning algorithms and neuroimaging types. Among 16 papers,
4 studies used a hybrid method to combine deep learning and
traditional machine learning approaches as a classifier, and
12 studies used only deep learning approaches. In a limited
available neuroimaging data set, hybrid methods have produced
accuracies of up to 98.8% for AD classification and 83.7%
for prediction of conversion from MCI to AD. Deep learning
approaches have yielded accuracies of up to 96.0% for AD
classification and 84.2% for MCI conversion prediction. While
it is a source of concern when experiments obtain a high
accuracy using small amounts of data, especially if the method
is vulnerable to overfitting, the highest accuracy of 98.8% was
due to the SAE procedure, whereas the 96% accuracy was due
to the amyloid PET scan, which included pathophysiological
information regarding AD. The highest accuracy for the AD
classification was 87% when 3DCNN was applied from the
MRI without the feature extraction step (Cheng et al., 2017).
Therefore, two or more multimodal neuroimaging data types
have been shown to produce higher accuracies than a single
neuroimaging type.
In traditional machine learning, well-defined features
influence performance results. However, the greater the
complexity of the data, the more difficult it is to select optimal
features. Deep learning identifies optimal features automatically
from the data (i.e., the classifier trained by deep learning finds
features that have an impact on diagnostic classification without
human intervention). Because of its ease-of-use and better
performance, deep learning has been used increasingly for
medical image analysis. The number of studies of AD using
CNN, which show better performance in image recognition
among deep learning algorithms, has increased drastically since
2015. This is consistent with a previous survey showing that
the use of deep learning for lesion classification, detection,
and segmentation has also increased rapidly since 2015
(Litjens et al., 2017).
Recent trends in the use of deep learning are aimed at
faster analysis with better accuracy than human practitioners.
Google’s well-known study for the diagnostic classification
of diabetic retinopathy (Gulshan et al., 2016) showed
classification performance that goes well beyond that of a
skilled professional. The diagnostic classification by deep
learning needs to show consistent performance under various
conditions, and the predicted classifier should be interpretable.
In order for diagnostic classification and prognostic prediction
using deep learning to reach readiness for real world
clinical applicability, several issues need to be addressed, as
discuss below.
Transparency
Traditional machine learning approaches may require expert
involvement in preprocessing steps for feature extraction and
selection from images. However, since deep learning does not
require human intervention but instead extracts features directly
from the input images, the data preprocessing procedure is
not routinely necessary, allowing flexibility in the extraction
of properties based on various data-driven inputs. Therefore,
deep learning can create a good, qualified model at each
time of the run. The flexibility has shown deep learning to
achieve a better performance than other traditional machine
learning that relies on preprocessing (Bengio, 2013). However,
this aspect of deep learning necessarily brings uncertainty over
which features would be extracted at every epoch, and unless
there is a special design for the feature, it is very difficult to
show which specific features were extracted within the networks
(Goodfellow et al., 2016). Due to the complexity of the deep
learning algorithm, which has multiple hidden layers, it is also
difficult to determine how those selected features lead to a
conclusion and to the relative importance of specific features or
subclasses of features. This is a major limitation for mechanistic
studies where understanding the informativeness of specific
features is desirable for model building. These uncertainties
and complexities tend to make the process of achieving high
accuracy opaque and also make it more difficult to correct
any biases that arise from a given data set. This lack of
clarity also limits the applicability of obtained results to other
use cases.
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The issue of transparency is linked to the clarity of the
results from machine learning and is not a problem limited to
deep learning (Kononenko, 2001). Despite the simple principle,
the complexity of the algorithm makes it difficult to describe
mathematically. When one perceptron advances to a neural
network by adding more hidden layers, it becomes even more
difficult to explain why a particular prediction was made. AD
classification based on 3D multimodal medical images with
deep learning involves non-linear convolutional layers and
pooling that have different dimensionality from the source data,
making it very difficult to interpret the relative importance
of discriminating features in original data space. This is a
fundamental challenge in view of the importance of anatomy
in the interpretation of medical images, such as MRI or
PET scans. The more advanced algorithm generates plausible
results, but the mathematical background is difficult to explain,
although the output for diagnostic classification should be clear
and understandable.
Reproducibility
Deep learning performance is sensitive to the random numbers
generated at the start of training, and hyper-parameters, such
as learning rates, batch sizes, weight decay, momentum, and
dropout probabilities, may be tuned by practitioners (Hutson,
2018). To produce the same experimental result, it is important
to set the same random seeds on multiple levels. It is also
important to maintain the same code bases (Vaswani et al.,
2018), even though the hyper-parameters and random seeds were
not, in most cases, provided in our study. The uncertainty of
the configuration and the randomness involved in the training
procedure may make it difficult to reproduce the study and
achieve the same results.
When the available neuroimaging data is limited, careful
consideration at the architectural level is needed to avoid the
issues of overfitting and reproducibility. Data leakage in machine
learning (Smialowski et al., 2009) occurs when the data set
framework is designed incorrectly, resulting in a model that uses
inessential additional information for classification. In the case
of diagnostic classification for the progressive and irreversible
Alzheimer’s disease, all subsequent MRI images should be labeled
as belonging to a patient with Alzheimer’s disease. Once the brain
structure of the patient is shared by both the training and testing
sets, the morphological features of the patient’s brain greatly
influence the classification decision, rather than the biomarkers
of dementia. In the present study, articles were excluded from the
review if the data set configurations did not explicitly describe
how to prevent data leakage (Figure 4).
Future studies ultimately need to replicate key findings from
deep learning on entirely independent data sets. This is now
widely recognized in genetics (König, 2011; Bush and Moore,
2012) and other fields but has been slow to penetrate deep
learning studies employing neuroimaging data. Hopefully the
emerging open ecology of medical research data, especially in the
AD and related disorders field (Toga et al., 2016; Reas, 2018), will
provide a basis to remediate this problem.
OUTLOOK AND FUTURE DIRECTION
Deep Learning algorithms and applications continue to evolve,
producing the best performance in closed-ended cases, such as
image recognition (Marcus, 2018). It works particularly well
when inference is valid, i.e., the training and test environments
are similar. This is especially true in the study of AD when
using neuroimages (Litjens et al., 2017). One weakness of
deep learning is that it is difficult to modify potential bias in
the network when the complexity is too great to guarantee
transparency and reproducibility. The issue may be solved
through the accumulation of large-scale neuroimaging data and
by studying the relationships between deep learning and features.
Disclosing the parameters used to obtain the results and mean
values from sufficient experimentations can mitigate the issue
of reproducibility.
Not all problems can be solved with deep learning.
Deep learning that extracts attributes directly from the
input data without preprocessing for feature selection
has difficulty integrating different formats of data as an
input, such as neuroimaging and genetic data. Because
the adjustment of weights for the input data is performed
automatically within a closed network, adding additional
input data into the closed network causes confusion
and ambiguity. A hybrid approach, however, puts the
additional information into machine learning parts and the
neuroimages into deep learning parts before combining the
two results.
Progress will be made in deep learning by overcoming
these issues while presenting problem-specific solutions. As
more and more data are acquired, research using deep
learning will become more impactful. The expansion of 2D
CNN into 3D CNN is important, especially in the study of
AD, which deals with multimodal neuroimages. In addition,
Generative Adversarial Networks (GAN) (Goodfellow et al.,
2014) may be applicable for generating synthetic medical images
for data augmentation. Furthermore, reinforcement learning
(Sutton and Barto, 2018), a form of learning that adapts to
changes in data as it makes its own decision based on the
environment, may also demonstrate applicability in the field
of medicine.
AD research using deep learning is still evolving to
achieve better performance and transparency. As multimodal
neuroimaging data and computer resources grow rapidly,
research on the diagnostic classification of AD using deep
learning is shifting toward a model that uses only deep learning
algorithms rather than hybrid methods, although methods need
to be developed to integrate completely different formats of data
in a deep learning network.
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